Partner Headlines - FOLD

  1. Morning Market Movers

    Benzinga
  2. Amicus Extending Rally On Upgrades

    Benzinga
  3. Benzinga's Top Upgrades

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. Morning Market Movers

    Benzinga
  6. Benzinga's Top #PreMarket Gainers

    Benzinga
  7. Earnings Scheduled For March 3, 2014

    Benzinga
  8. UPDATE: J.P. Morgan Downgrades Amicus Therapeutics On Cautious ...

    Benzinga
  9. Gilead Sciences Leads In Rising Short Interest Among Biotechs ...

    Benzinga
  10. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics ...

    Benzinga
  11. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, ...

    Benzinga
  12. Amicus, Biogen Announce Deal for Discovery, Development, Commercialization ...

    Benzinga
  13. Amicus Therapeutics Says Added 6-Month Results from Phase 3 Fabry ...

    Benzinga
  14. Amicus Therapeutics Advances Chaperone-ERT Combo Platform in ...

    Benzinga
  15. Amicus Announces Positive Phase 2 Results for Chaperone-Enzyme ...

    Benzinga
  16. Stocks Hitting 52-Week Lows

    Benzinga
  17. UPDATE: Wedbush Downgrades Amicus Therapeutics to Underperform ...

    Benzinga
  18. Option Traders Call a Bottom for Amicus Therapeutics

    SchaeffersResearch
  19. GlaxoSmithKline

    IBD
  20. Amicus, Glaxo Release Top-Line Six-Month Primary Treatment Period ...

    Benzinga
  21. Amicus Therapeutics Announces Additional Preliminary Results ...

    Benzinga
  22. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-Q)

    GuruFocus
  23. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-Q)

    GuruFocus
  24. UPDATE: Canaccord Reiterates Buy Rating, Raises PT on Amicus ...

    Benzinga
  25. Amylin Pharmaceuticals, Best Buy Among Stocks Up on High Volume ...

    FoxBusiness
  26. Benzinga's Top Upgrades with Color for May 8, 2012

    Benzinga
  27. UPDATE: J.P. Morgan Upgrades Amicus Therapeutics

    Benzinga
  28. From Earlier: Amicus Therapeutics Prices Underwritten Offering ...

    Benzinga
  29. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-K)

    GuruFocus
  30. Amicus Therapeutics Presents Preclinical Studies of Chaperone ...

    Benzinga
  31. Amicus Therapeutics Announces Positive Preliminary Results From ...

    Benzinga
Trading Center